Breaking News: PPLPHARMA Next 200 Target

ICICI Securities Re-Initiates Coverage on Piramal Pharma with Buy Rating - 22 Dec, 2023. Piramal Pharma Ltd's stock surges over 8% to hit a 52-week high of Rs 140.20 on the BSE after ICICI Securities re-initiated coverage with a buy rating and set a target price of Rs 180.

cup and handle pattern you can see weekly chart why i say 200 targethttps://www.tradingview.com/x/ng1YC5Ac/